Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal iron vs ferrous sulfate for iron deficiency anemia in pregnancy and postpartum
2016-000609-36Phase 4Active
- Sponsor
- Vall d'Hebron University Hospital
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ferric pyrophosphate in iron deficiency anemia (IDA) (2 arms), sponsored by Vall d'Hebron University Hospital. Primary endpoint: Evolution of hemoglobin levels throughout the treatment. Started Apr 2019; status: active.
02
Drugs
ferric pyrophosphate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2016-000609-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000609-36.